According to GlobalData, LUTONIX 018 is one of 10 product lines sold in the US pta peripheral deb catheters market; these product lines are sold by 4 different manufacturers. The average selling price for LUTONIX 018 increased in hospitals, decreased in health systems, and increased outside of hospital facilities in 2022. The price of the LUTONIX 018 device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Becton Dickinson and Co apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Becton Dickinson and Co overview

Becton Dickinson and Co (BD) is a medical technology company, which manufactures and sells medical devices, reagents, and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; pre-fillable drug delivery systems; respiratory ventilation and diagnostic equipment and consumables; products for the safe collection and transportation of diagnostic specimens; instruments and reagent systems to detect a range of infectious diseases and cancers; and clinical research tools. BD offers its products for life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry, and general public. The company markets its products in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. BD is headquartered in New Jersey, the US.

For a complete picture of LUTONIX 018, PTA Peripheral DEB Catheters pricing in the US, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.